Literature DB >> 24373424

Neurotoxicological profile assessment of lobeline after acute treatment in mice.

Laise C Lima Verde Rodrigues1, Natália Decker, Jaqueline N Picada, Patrícia Pereira.   

Abstract

Lobeline is a natural alkaloid with high affinity for nicotinic acetylcholine receptors, and it is a promising candidate for addiction treatment in human beings. This work evaluated the toxicological profile of lobeline with different behavioural models and investigated its effect on DNA damage (comet assay and micronucleus test) in mice. Acute administration of lobeline (5 or 10 mg/kg; i.p.) did not impair the parameters measured in the habituation and inhibitory avoidance test, suggesting that it has no effect on memory acquisition in these tasks. Lobeline did not affect the number or the latency to the first head-dip in the hole board test, indicating that it was not anxiolytic/anxiogenic in this model. No genotoxic effects were observed in blood, liver and brain tissues collected 24 hr after the single injection of lobeline (both doses). There was no increase in micronucleus frequency in mice treated with lobeline, indicating the absence of toxicity in bone marrow of the animals. Therefore, the acute treatment with high doses of lobeline did not impair the behavioural parameters measured in this work. Additionally, the drug was not able to produce DNA damage.
© 2013 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24373424     DOI: 10.1111/bcpt.12189

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  1 in total

1.  DNA damage and oxidative stress induced by seizures are decreased by anticonvulsant and neuroprotective effects of lobeline, a candidate to treat alcoholism.

Authors:  Liana Dantas da Costa E Silva; Patrícia Pereira; Gabriela Gregory Regner; Fernanda Brião Menezes Boaretto; Cleonice Hoffmann; Pricila Pflüger; Lucas Lima da Silva; Luiza Reinhardt Steffens; Ana Moira Morás; Dinara Jaqueline Moura; Jaqueline Nascimento Picada
Journal:  Metab Brain Dis       Date:  2017-10-14       Impact factor: 3.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.